Thoracic dysplasia-hydrocephalus syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1861OMIM:273730Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thoracic dysplasia-hydrocephalus syndrome, also known as Beemer-Langer syndrome or Beemer lethal malformation syndrome, is an extremely rare genetic disorder characterized by the combination of a narrow or underdeveloped thorax (short-rib thoracic dysplasia) and hydrocephalus (abnormal accumulation of cerebrospinal fluid in the brain). This condition primarily affects the skeletal system and the central nervous system. It was first described in the medical literature in the 1980s. The hallmark features include severe shortening of the ribs leading to a small, narrow chest cavity, which can critically compromise lung development and respiratory function. Hydrocephalus causes increased intracranial pressure and enlargement of the head. Additional features that have been reported include short limbs, polydactyly (extra fingers or toes), and other skeletal abnormalities. Facial dysmorphism, including a flat midface, may also be present. Internal organ anomalies, particularly of the heart and kidneys, have been described in some cases. This condition is typically lethal in the neonatal period, primarily due to respiratory insufficiency caused by the severely underdeveloped thorax and lungs. Because of its extreme rarity and early lethality, there are no established treatments beyond supportive care. Management focuses on palliative measures and may include genetic counseling for affected families. The syndrome should be distinguished from other short-rib thoracic dysplasias, including Jeune syndrome and short-rib polydactyly syndromes, which share overlapping skeletal features.

Clinical phenotype terms— hover any for plain English:

Communicating hydrocephalusHP:0001334
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thoracic dysplasia-hydrocephalus syndrome.

View clinical trials →

No actively recruiting trials found for Thoracic dysplasia-hydrocephalus syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thoracic dysplasia-hydrocephalus syndrome community →

No specialists are currently listed for Thoracic dysplasia-hydrocephalus syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thoracic dysplasia-hydrocephalus syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thoracic dysplasia-hydrocephalus syndromeForum →

No community posts yet. Be the first to share your experience with Thoracic dysplasia-hydrocephalus syndrome.

Start the conversation →

Latest news about Thoracic dysplasia-hydrocephalus syndrome

No recent news articles for Thoracic dysplasia-hydrocephalus syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thoracic dysplasia-hydrocephalus syndrome

What is Thoracic dysplasia-hydrocephalus syndrome?

Thoracic dysplasia-hydrocephalus syndrome, also known as Beemer-Langer syndrome or Beemer lethal malformation syndrome, is an extremely rare genetic disorder characterized by the combination of a narrow or underdeveloped thorax (short-rib thoracic dysplasia) and hydrocephalus (abnormal accumulation of cerebrospinal fluid in the brain). This condition primarily affects the skeletal system and the central nervous system. It was first described in the medical literature in the 1980s. The hallmark features include severe shortening of the ribs leading to a small, narrow chest cavity, which can cr

How is Thoracic dysplasia-hydrocephalus syndrome inherited?

Thoracic dysplasia-hydrocephalus syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Thoracic dysplasia-hydrocephalus syndrome typically begin?

Typical onset of Thoracic dysplasia-hydrocephalus syndrome is neonatal. Age of onset can vary across affected individuals.